ArticleCureus2025
Exploring Home-Visit Rehabilitation for Terminally Ill Patients With Cancer: Insights From Japanese Care Managers.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCare managers (CMs) play a vital role in planning, managing, providing family support, and coordinating services for individuals in need, particularly in the field of palliative care. To implement home-visit rehabilitation for terminally ill patients with cancer effectively, it is essential for the care plan created by the CM to be incorporated into the system. Collaboration with the CM is key to ensuring the successful implementation of rehabilitation. Despite this necessity, there is a lack of studies investigating the background and challenges preventing progress in this area. Therefore, this study aimed to clarify the current status of home-visit rehabilitation for terminally ill patients with cancer, focusing on CMs. By identifying associated factors, we aim to suggest guidelines for promoting the use of home-visit rehabilitation to maintain and improve the quality of life of terminally ill patients with cancer in their home settings.
methodsA self-administered survey was mailed or distributed directly to CMs. It collected the following 11 types of information: gender, age, years of work experience, basic job title, working form, office management system, experience with home-visit rehabilitation (including for terminally ill patients with cancer), perception and importance of this service, and reasons for not implementing it for terminally ill patients with cancer. T-tests or chi-square tests were conducted to examine the association between home-visit rehabilitation experiences and sociodemographic data, as well as the relationship between home-visit rehabilitation for terminally ill patients with cancer, sociodemographic data, and perceptions of and need for home-visit rehabilitation.
resultsOut of 520 questionnaires distributed across seven regions in three prefectures, 388 were returned, resulting in a response rate of 74.6%. After excluding incomplete responses, data from 357 respondents were considered valid. Age (p = 0.004), years of work experience (p < 0.001), and working form (p < 0.001) were found to be related to home-visit rehabilitation experience. A significant association was identified between home-visit rehabilitation experience for terminally ill patients with cancer and years of work experience (p < 0.001), and the perception (p < 0.001) and necessity (p = 0.001) for home-visit rehabilitation.
conclusionsThese results suggest that promoting palliative rehabilitation for terminally ill patients with cancer in home care requires actively encouraging CMs to develop a shared understanding of the services and their role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.